IPHA logo

Innate Pharma SA (IPHA) Working Capital

IPHA Annual Working Capital

$119.80 M
+$14.17 M+13.42%

31 December 2023

IPHA Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

IPHA Quarterly Working Capital

$78.65 M
-$41.15 M-34.35%

30 June 2024

IPHA Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

IPHA Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+13.4%-32.2%
3 y3 years-23.9%-32.2%
5 y5 years-14.8%-32.2%

IPHA Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+81.3%-34.4%+19.0%
5 y5-year-23.9%+81.3%-50.0%+19.0%
alltimeall time-42.9%+434.0%-70.4%+198.8%

Innate Pharma SA Working Capital History

DateAnnualQuarterly
June 2024
-
$78.65 M(-34.4%)
Dec 2023
$119.80 M(+13.4%)
$119.80 M(+3.2%)
June 2023
-
$116.05 M(+9.9%)
Dec 2022
$105.62 M(+59.8%)
$105.62 M(+2.9%)
June 2022
-
$102.62 M(+55.3%)
Dec 2021
$66.09 M(-58.0%)
$66.09 M(-36.2%)
June 2021
-
$103.61 M(-34.2%)
Dec 2020
$157.39 M(+21.4%)
$157.39 M(+72.0%)
June 2020
-
$91.49 M(-29.5%)
Dec 2019
$129.70 M(-7.7%)
$129.70 M(-6.6%)
June 2019
-
$138.86 M(-1.2%)
Dec 2018
$140.59 M(+84.2%)
$140.59 M(+119.4%)
June 2018
-
$64.08 M(-16.0%)
Dec 2017
$76.32 M(-53.0%)
$76.32 M(-44.3%)
June 2017
-
$136.98 M(-15.7%)
Dec 2016
$162.42 M(-22.6%)
$162.42 M(+0.3%)
June 2016
-
$161.99 M(-22.8%)
DateAnnualQuarterly
Dec 2015
$209.87 M(+151.8%)
$209.87 M(-20.9%)
June 2015
-
$265.39 M(+218.4%)
Dec 2014
$83.34 M(+50.6%)
$83.34 M(-21.9%)
June 2014
-
$106.72 M(+92.9%)
Dec 2013
$55.33 M(+63.2%)
$55.33 M(+110.3%)
June 2013
-
$26.32 M(-22.4%)
Dec 2012
$33.90 M(-30.2%)
$33.90 M(-10.8%)
June 2012
-
$38.00 M(-21.7%)
Dec 2011
$48.55 M(+9.7%)
$48.55 M(+29.9%)
June 2011
-
$37.39 M(-15.6%)
Dec 2010
$44.27 M(-34.1%)
$44.27 M(-10.2%)
June 2010
-
$49.32 M(-26.6%)
Dec 2009
$67.21 M(+34.3%)
$67.21 M
Dec 2008
$50.05 M(-23.9%)
-
Dec 2007
$65.75 M(-8.1%)
-
Dec 2006
$71.55 M(+219.0%)
-
Dec 2005
$22.43 M
-

FAQ

  • What is Innate Pharma SA annual working capital?
  • What is the all time high annual working capital for Innate Pharma SA?
  • What is Innate Pharma SA annual working capital year-on-year change?
  • What is Innate Pharma SA quarterly working capital?
  • What is the all time high quarterly working capital for Innate Pharma SA?
  • What is Innate Pharma SA quarterly working capital year-on-year change?

What is Innate Pharma SA annual working capital?

The current annual working capital of IPHA is $119.80 M

What is the all time high annual working capital for Innate Pharma SA?

Innate Pharma SA all-time high annual working capital is $209.87 M

What is Innate Pharma SA annual working capital year-on-year change?

Over the past year, IPHA annual working capital has changed by +$14.17 M (+13.42%)

What is Innate Pharma SA quarterly working capital?

The current quarterly working capital of IPHA is $78.65 M

What is the all time high quarterly working capital for Innate Pharma SA?

Innate Pharma SA all-time high quarterly working capital is $265.39 M

What is Innate Pharma SA quarterly working capital year-on-year change?

Over the past year, IPHA quarterly working capital has changed by -$37.41 M (-32.23%)